Nanopharmacology focuses on the design, development, and application of nanoscale materials for medical purposes. At the intersection of nanotechnology and pharmacology, this discipline harnesses the unique properties of nanoparticles to revolutionize drug delivery and therapeutic interventions. Nanoparticles, often ranging in size from 1 to 100 nanometers, offer distinct advantages such as increased surface area, enhanced bioavailability, and targeted delivery to specific cells or tissues. In the realm of pharmaceuticals, nanopharmacology holds the promise of overcoming challenges associated with conventional drug delivery systems, including poor solubility and systemic side effects.
By precisely manipulating the physicochemical properties of nanoparticles, researchers aim to optimize drug formulations, improve therapeutic efficacy, and minimize adverse reactions. This field's potential extends beyond drug delivery, as nanopharmacology also explores diagnostic applications and personalized medicine, showcasing its transformative impact on the future of healthcare. As scientists delve deeper into understanding the intricate interactions at the nanoscale, nanopharmacology emerges as a frontier with vast implications for advancing pharmaceutical science and patient care.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India